You are here
Combined oestrogen-progestin contraception
Deep vein thrombosis - Combined oestrogen-progestin contraception Factor
Last reviewed for CCPS 22 December 2008.
Investigative Documents
Claimant Report - Combined Oestrogen-Progestin Contraception - Deep Vein Thrombosis [CR9305] Preliminary questions [21247]
1169 — the veteran is a woman. the veteran used combined oestrogen-progestin contraception for a period of at least three weeks within the 90 days before the clinical onset of the condition under consideration. 21391 — the veteran has established the causal connection between combined oestrogen-progestin contraception and VEA service for the clinical onset of deep vein thrombosis. 21392 — the veteran has established the causal connection between combined oestrogen-progestin contraception and operational service for the clinical onset of deep vein thrombosis. or 21393 — the veteran has established the causal connection between combined oestrogen-progestin contraception and eligible service for the clinical onset of deep vein thrombosis. Clinical onset and operational service [21392] Clinical onset and eligible service [21393]